DK0654256T3 - Bionedbrydelig senehindetampon - Google Patents

Bionedbrydelig senehindetampon

Info

Publication number
DK0654256T3
DK0654256T3 DK94907661T DK94907661T DK0654256T3 DK 0654256 T3 DK0654256 T3 DK 0654256T3 DK 94907661 T DK94907661 T DK 94907661T DK 94907661 T DK94907661 T DK 94907661T DK 0654256 T3 DK0654256 T3 DK 0654256T3
Authority
DK
Denmark
Prior art keywords
drug
sclera
surgical operation
vitreous body
plug
Prior art date
Application number
DK94907661T
Other languages
English (en)
Inventor
Yuichiro Ogura
Yoshito Ikada
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0654256T3 publication Critical patent/DK0654256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK94907661T 1993-02-26 1994-02-23 Bionedbrydelig senehindetampon DK0654256T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6281493 1993-02-26
JP6945793 1993-03-04
PCT/JP1994/000273 WO1994018921A1 (en) 1993-02-26 1994-02-23 Biodegradable sclera plug

Publications (1)

Publication Number Publication Date
DK0654256T3 true DK0654256T3 (da) 2000-12-18

Family

ID=26403867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94907661T DK0654256T3 (da) 1993-02-26 1994-02-23 Bionedbrydelig senehindetampon

Country Status (12)

Country Link
EP (1) EP0654256B1 (da)
KR (1) KR100313268B1 (da)
AT (1) ATE195065T1 (da)
CA (1) CA2118515A1 (da)
DE (1) DE69425411T2 (da)
DK (1) DK0654256T3 (da)
ES (1) ES2150487T3 (da)
FI (1) FI945014L (da)
GR (1) GR3034526T3 (da)
NO (1) NO303665B1 (da)
PT (1) PT654256E (da)
WO (1) WO1994018921A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001156A1 (en) 1997-07-02 1999-01-14 Santen Pharmaceutical Co., Ltd. Polylactic acid scleral plugs
US6991650B2 (en) 1997-10-08 2006-01-31 Refocus Ocular, Inc. Scleral expansion device having duck bill
US7008396B1 (en) 1999-09-03 2006-03-07 Restorvision, Inc. Ophthalmic device and method of manufacture and use
US6375642B1 (en) * 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
EP3167872B1 (en) * 2000-07-05 2020-10-14 Allergan, Inc. Methods for treating inflammation-mediated conditions of the eye
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US20040137059A1 (en) 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
WO2005056764A2 (en) 2003-12-05 2005-06-23 Compound Therapeutics, Inc. Inhibitors of type 2 vascular endothelial growth factor receptors
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
EP3351211B1 (en) 2006-07-11 2023-09-06 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
JP5537946B2 (ja) 2006-11-22 2014-07-02 ブリストル−マイヤーズ スクイブ カンパニー Ｉｇｆ−ｉｒを含むチロシンキナーゼ受容体に対する改変タンパク質に基づく標的治療薬
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
JP2011517314A (ja) 2008-02-14 2011-06-02 ブリストル−マイヤーズ スクイブ カンパニー Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬
PE20091931A1 (es) 2008-05-22 2009-12-31 Bristol Myers Squibb Co Proteinas de dominio de armazon basadas en fibronectina multivalentes
TWI496582B (zh) 2008-11-24 2015-08-21 必治妥美雅史谷比公司 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
US9562089B2 (en) 2010-05-26 2017-02-07 Bristol-Myers Squibb Company Fibronectin based scaffold proteins having improved stability
KR101750651B1 (ko) * 2016-01-28 2017-06-23 동국대학교 산학협력단 약물 잔류 방지능 및 재충전 기능을 갖는 안구 내 약물 주입 장치
CN106667656A (zh) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 生物可降解泪道栓及其制备方法和应用
CN109789011B (zh) 2016-10-03 2021-09-17 加州理工学院 放射发光光疗眼部设备
US11400307B2 (en) 2018-01-31 2022-08-02 California Institute Of Technology Controllable ocular phototherapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4634418A (en) * 1984-04-06 1987-01-06 Binder Perry S Hydrogel seton
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5098443A (en) * 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
JPH04364857A (ja) * 1991-06-12 1992-12-17 Asahi Chem Ind Co Ltd 涙道せき止め用ロッド

Also Published As

Publication number Publication date
CA2118515A1 (en) 1994-02-23
NO944060D0 (no) 1994-10-25
ATE195065T1 (de) 2000-08-15
FI945014A7 (fi) 1994-10-25
KR950701209A (ko) 1995-03-23
FI945014A0 (fi) 1994-10-25
NO944060L (no) 1994-10-25
EP0654256B1 (en) 2000-08-02
ES2150487T3 (es) 2000-12-01
WO1994018921A1 (en) 1994-09-01
NO303665B1 (no) 1998-08-17
EP0654256A4 (en) 1995-01-04
PT654256E (pt) 2000-12-29
GR3034526T3 (en) 2000-12-29
DE69425411T2 (de) 2001-02-08
DE69425411D1 (de) 2000-09-07
KR100313268B1 (ko) 2002-11-22
EP0654256A1 (en) 1995-05-24
FI945014L (fi) 1994-10-25

Similar Documents

Publication Publication Date Title
ATE195065T1 (de) Biologisch abbaubarer sklerastopfen
Tomey et al. The glaucomas in aphakia and pseudophakia
KESSLER Experiments in refilling the lens
BR0010869A (pt) Método para administrar um corticosteróide a um segmento posterior de um olho e dispositivo de liberação sustentada implantável
BRPI0406692A (pt) Implante ocular biodegradável
EA199900811A1 (ru) Композиция для офтальмологических хирургических операций (варианты) и способ их осуществления
SE8403090D0 (sv) Gel for anvendning som glaskroppssubstitut
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE343983T1 (de) Ophthalmologisches implantat
NZ516513A (en) Nitric oxide donors for inducing neurogenesis
SE9101840D0 (sv) New medicinal use
DK0403360T3 (da) Anvendelse af phenylethanolaminer til fremstilling af et lægemiddel mod øjenlidelser
FR2757064B1 (fr) Lentille intraoculaire contenant un medicament relargable
DK0410749T3 (da) Anthocyanidiner til behandling af ophthalmiske sygdomme
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
Knapp THE SURGICAL TREATMENT OF ORBITAL COMPLICATIONS IN DISEASE OF THE NASAL ACCESSORY SINUSES.
RU2245122C2 (ru) Способ экстракции твердых катаракт
SU1291142A1 (ru) Способ лечени отечных дистрофий роговицы
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
SU1597187A1 (ru) Способ удалени дра хрусталика и хрусталиковых масс из передней камеры глаза
RU97105890A (ru) Способ хирургического лечения осложненной катаракты и подвывиха хрусталика, сочетанных с отслойкой сетчатки
PARK et al. Postoperative recurrence rate of scleral fixation technique and bare scleral technique in primary pterygium operation
Suzuki et al. Laser Trabeculostimulation in Open-Angle Glaucoma: A New Trial: Part I
Scheie et al. Choice of a Miotic Agent Following Retrobulbar Anesthesia
UA19588A (uk) Спосіб екстракції травматичhої катаракти з пошкоджеhhям задhьої капсули кришталика